Patents Assigned to The University
  • Publication number: 20150152547
    Abstract: By using chemical vapor deposition or chemical vapor infiltration, silicon carbide is deposited on a preform 100 accommodated in a reaction furnace 11 for film formation, and the amount of additive gas added to raw material gas and carrier gas to be supplied to the reactive furnace 11 is used to control the growth rate and filling uniformity at film formation of silicon carbide. When the film formation of silicon carbide follows a first-order reaction, the amount of added additive gas is used to control the sticking probability of the film-forming species. When the film formation of silicon carbide follows a Langmuir-Hinshelwood rate formula, the amount of added additive gas is used to make a control so that a zero-order reaction region of the Langmuir-Hinshelwood rate formula is used.
    Type: Application
    Filed: February 12, 2015
    Publication date: June 4, 2015
    Applicants: IHI Corporation, The University of Tokyo
    Inventors: Takeshi NAKAMURA, Masato ISHIZAKI, Kenji FUCHIGAMI, Kozue HOTOZUKA, Yukihiro SHIMOGAKI, Takeshi MOMOSE, Yasuyuki FUKUSHIMA, Noboru SATO, Yuichi FUNATO, Hidetoshi SUGIURA
  • Publication number: 20150150965
    Abstract: The present invention is based on the identification of the adjuvant properties of inorganic (metal/metal oxide) nanoparticles. As such, the invention provides an adjuvant comprising, consisting or consisting essentially of inorganic nanoparticle. The invention also provides compositions and vaccines comprising the same as well as methods which exploit the adjuvant inorganic nanoparticles.
    Type: Application
    Filed: March 15, 2013
    Publication date: June 4, 2015
    Applicant: The University Court of the University of Edinburg
    Inventors: Sara Howie, Kenneth Donaldson, Wan Seob Cho
  • Publication number: 20150152049
    Abstract: The present invention provides materials and methods to induce cell death by methuosis, a non-apoptotic cell death mechanism, to induce vacuolization without cell death, or to induce cell death without vacuolization. Small molecules herein are useful for treating cell proliferation disorders or anomalies, particularly, but not exclusively, cancer. Methods related to the research and pharmaceutical use of the small molecules are also provided herein.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 4, 2015
    Applicant: The University of Toledo
    Inventors: William A. Maltese, Paul W. Erhardt, Jean H. Overmeyer, Christopher Trabbic
  • Publication number: 20150150954
    Abstract: The invention relates to methods of using an effective amount of activated protein C (APC) to treat an individual for a skin disorder characterised by the presence of hyperproliferative keratinocytes.
    Type: Application
    Filed: July 4, 2013
    Publication date: June 4, 2015
    Applicant: The University of Sydney
    Inventors: Christopher John Jackson, Meilang Xue
  • Patent number: 9044347
    Abstract: A hybrid bioelectrical interface (HBI) device can be an implantable device comprising an abiotic component operable to transmit charge via electrons or ions; a biological component interfacing with the neural tissue, the biological component being sourced from biologic, biologically-derived, or bio-functionalized material; and a conjugated polymer component that together provide a way to chronically interface living neural tissue with electronic devices for extended durations (e.g. greater than 10 years). In some embodiments, conjugated polymers provide a functional electrical interface for charge transfer and signal transduction between the nervous system and an electronic device (e.g. robotic prosthetic limb, retinal implant, microchip).
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: June 2, 2015
    Assignee: The Regents of The University of Michigan
    Inventors: Paul S. Cederna, Brent M. Egeland, Mohammad Reza Abidian, Antonio Peramo, Melanie G. Urbanchek, Daryl R. Kipke, Sarah Richardson-Burns, David C. Martin, Eugene D. Daneshvar
  • Patent number: 9045434
    Abstract: A compound and method for treating myocilin glaucoma using a selective Grp94 inhibitor is presented. Clearance of mutant myocilin can be promoted by selectively targeting the endoplasmic reticulum (ER) chaperone Grp94 using siRNA knockdown or small molecule inhibitors. Grp94 contributes to the intracellular accumulation of mutant myocilin. Tailored treatments aimed at disrupting the Grp94/mutant myocilin interaction can be used as a new therapeutic strategy for myocilin glaucoma. The inventors developed a compound having a general backbone structure of geldanamycin (GDA) and radicicol (RDC) in which a more hydrophobic surrogate of the quinone in GDA is linked to the resorcinol in RDC through a cis-amide bioisostere.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: June 2, 2015
    Assignees: University of South Florida, The University of Kansas
    Inventors: Chad Anthony Dickey, Amirthaa Suntharalingam, Brian S. J. Blagg
  • Patent number: 9049676
    Abstract: A method of spatial modulation and associated transmission apparatus, receiver apparatus, computer program product and system for identifying a transmitter element within a transmission array of at least two transmitter elements, wherein a signal is transmitted by one active transmitter element at a time over a channel to a receiver. Power is allocated to the transmitter elements, wherein the power is allocated differently between at least two transmitter elements. The transmitted data is received at the receiver. The location of the active transmitter element is detected using knowledge of the power allocated to the transmitter elements.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: June 2, 2015
    Assignee: The University Court of the University of Edinburgh
    Inventors: Harald Haas, Marco Di Renzo
  • Patent number: 9048330
    Abstract: A three-dimensional Gate-Wrap-Around Field-Effect Transistor (GWAFET). The GWAFET includes a substrate of III-V semiconductor material. The GWAFET further includes one or more channel layers with a gate wrapped around these one or more channel layers. Additionally, the GWAFET includes a barrier layer residing on the top channel layer with a layer of doped III-V semiconductor material residing on each end of the barrier layer. A source and drain contact are connected to the layer of doped III-V semiconductor material as well as to the multiple channels in the embodiment with the GWAFET including multiple channel layers. By having such a structure, integration density is improved. Furthermore, electrostatic control is improved due to gate coupling, which helps reduce standby power consumption. Furthermore, by using III-V semiconductor material as opposed to silicon, the current drive capacity is improved.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: June 2, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jack C. Lee, Fei Xue
  • Patent number: 9045699
    Abstract: A hydrocarbonaceous material upgrading method may involve a novel combination of heating, vaporizing and chemically reacting hydrocarbonaceous feedstock that is substantially unpumpable at pipeline conditions, and condensation of vapors yielded thereby, in order to upgrade that feedstock to a hydrocarbonaceous material condensate that meets crude oil pipeline specification.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: June 2, 2015
    Assignee: The University of Wyoming Research Corporation
    Inventors: Charles G. Mones, Frank D. Guffey, Phyllis J. Brecher
  • Patent number: 9044470
    Abstract: Provided are methods of treating or preventing viral infections caused by or associated with a Dengue virus using iminosugars.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: June 2, 2015
    Assignees: United Therapeutics Corporation, The Chancellor, Masters and Scholars of The University of Oxford
    Inventors: Urban Ramstedt, Brennan Klose, Nicole Zitzmann, Raymond A. Dwek, Terry D. Butters
  • Patent number: 9045778
    Abstract: A transgenic insect cell line for production of recombinant glycoproteins possessing sulfated, complex N-glycans is provided.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: June 2, 2015
    Assignee: The University of Wyoming
    Inventor: Donald L. Jarvis
  • Patent number: 9045512
    Abstract: This invention relates to galactosylceramide compounds.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: June 2, 2015
    Assignees: The Scripps Research Institute, Brigham Young University, The University of Chicago
    Inventors: Paul B. Savage, Albert Bendelac, Luc Teyton
  • Patent number: 9048658
    Abstract: A method of suppressing propagation of leakage current in an array of switching devices. The method includes providing a dielectric breakdown element integrally and serially connected to a switching element within each of the switching device. A read voltage (for example) is applied to a selected cell. The propagation of leakage current is suppressed by each of the dielectric breakdown element in unselected cells in the array. The read voltage is sufficient to cause breakdown in the selected cells but insufficient to cause breakdown in the serially connected, unselected cells in a specific embodiment. Methods to fabricate of such devices and to program, to erase and to read the device are provided.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: June 2, 2015
    Assignee: The Regents of The University of Michigan
    Inventors: Wei Lu, Sung Hyun Jo
  • Patent number: 9046530
    Abstract: The present invention provides Chlamydia proteins and fragments thereof and methods of use in diagnostic assays.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: June 2, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventor: Guangming Zhong
  • Patent number: 9044256
    Abstract: Medical devices having a platform and an arm movable between a collapsed position and an expanded position. In some embodiments, the platform comprises at least one of a magnetically-attractive material and a material capable of being magnetically-charged. Methods of use.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: June 2, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jeffrey A. Cadeddu, Daniel J. Scott, Raul Fernandez, Richard A. Bergs
  • Patent number: 9045710
    Abstract: Electrorheological fluids and methods include changes in liquid-like materials that can flow like milk and subsequently form solid-like structures under applied electric fields; e.g., about 1 kV/mm. Such fluids can be used in various ways as smart suspensions, including uses in automotive, defense, and civil engineering applications. Electrorheological fluids and methods include one or more polar molecule substituted polyhedral silsesquioxanes (e.g., sulfonated polyhedral silsesquioxanes) and one or more oils (e.g., silicone oil), where the fluid can be subjected to an electric field.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: June 2, 2015
    Assignee: The Regents of The University of Michigan
    Inventors: Peter F. Green, Ernest C. McIntyre
  • Publication number: 20150147573
    Abstract: The present invention is directed to nanofiber yarns, ribbons, and sheets; to methods of making said yarns, ribbons, and sheets; and to applications of said yarns, ribbons, and sheets. In some embodiments, the nanotube yarns, ribbons, and sheets comprise carbon nanotubes. Particularly, such carbon nanotube yarns of the present invention provide unique properties and property combinations such as extreme toughness, resistance to failure at knots, high electrical and thermal conductivities, high absorption of energy that occurs reversibly, up to 13% strain-to-failure compared with the few percent strain-to-failure of other fibers with similar toughness, very high resistance to creep, retention of strength even when heated in air at 450° C. for one hour, and very high radiation and UV resistance, even when irradiated in air. Furthermore these nanotube yarns can be spun as one micron diameter yarns and plied at will to make two-fold, four-fold, and higher fold yarns.
    Type: Application
    Filed: December 23, 2014
    Publication date: May 28, 2015
    Applicant: Board of Regents, The University of Texas System
    Inventors: Mei Zhang, Shaoli Fang, Ray H. Baughman, Anvar A. Zakhidov, Kenneth Ross Atkinson, Ali E. Aliev, Sergey Li, Chris Williams
  • Publication number: 20150147737
    Abstract: An educational system for visualizing sound by a student in a laboratory. The system includes a speaker powered by an audio amplifier. A function generator or a microphone controls the amplitude and frequency of pressure waves originating from the speaker. A model of the ear canal is suspended over the speaker, the model having a plastic pipe with two open ends and a membrane stretched taut over one of the open ends with constant tension. A mirror is affixed to the membrane, creating a mass-loaded membrane. A laser pointer emits light directed toward the mirror. A screen receives a light reflection pattern created by the light reflected from the minor, with the model ear canal, speaker, membrane, and mirror placed equidistant between the screen and the laser pointer. The system is adapted to demonstrate hearing sensitivity to a deaf or hearing-impaired person in an educational setting.
    Type: Application
    Filed: November 24, 2014
    Publication date: May 28, 2015
    Applicant: The University of Scarton
    Inventors: Nicholas P. Truncale, Michelle Graham
  • Publication number: 20150150153
    Abstract: The present invention provides novel methods for improving the efficiency of artificial activation of unfertilized mammalian oocytes by reducing the intracellular concentration of Zn2+ in the oocyte. The methods of the invention may additionally comprise a preceding step of increasing the intracellular concentration of Ca2+ in the oocyte prior to reduction of the intracellular Zn2+ concentration. The invention further provides unfertilized oocytes activated by the disclosed methods and viable mammalian animals produced from unfertilized oocytes activated by the disclosed methods.
    Type: Application
    Filed: November 26, 2014
    Publication date: May 28, 2015
    Applicant: The Curators of The University of Missouri
    Inventors: Kiho Lee, Randall S. Prather
  • Publication number: 20150144872
    Abstract: A semiconductor device includes a substrate supporting a plurality of layers that include at least one modulation doped quantum well (QW) structure offset from a quantum dot in quantum well (QD-in-QW) structure. The modulation doped QW structure includes a charge sheet spaced from at least one QW by a spacer layer. The QD-in-QW structure has QDs embedded in one or more QWs. The QD-in-QW structure can include at least one template/emission substructure pair separated by a barrier layer, the template substructure having smaller size QDs than the emission substructure. A plurality of QD-in-QW structures can be provided to support the processing (emission, absorption, amplification) of electromagnetic radiation of different characteristic wavelengths (such as optical wavelengths in range from 1300 nm to 1550 nm).
    Type: Application
    Filed: November 20, 2014
    Publication date: May 28, 2015
    Applicants: Opel Solar, Inc., The University of Connecticut
    Inventor: Geoff W. Taylor